Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
News
All
Editors' Picks
Stocks
Indices
Market Movers
Commodities
Cryptocurrencies
Forex
Presentations
Earnings
Transcripts
Technical Analysis
Economic Indicator
Other
Presentations
Artivion Q3 Revenue Rises 9% as Margins and Cash Flow Weaken
Artivion’s Q3 2026 revenue rose 9.2% on On-X and stent-graft growth, while margins, earnings and cash flow declined. The company narrowed its full-year outlook.
Artivion Inc
TradingKey
Fri, Nov 6
Technical Analysis
India FX Reserves, USD above expectations ($0B) in October 26: Actual ($717.06B)
Fxstreet
Fri, Nov 6
Forex
Australian Dollar plunges against US Dollar ahead of US NFP data
The Australian Dollar (AUD) faces intense selling pressure against the US Dollar (USD) on Friday. In the European trade, the AUD/USD pair posted a fresh seven-month low at 0.6862.
AUD/USD
Fxstreet
Fri, Nov 6
Presentations
Natera Raises 2026 Revenue Outlook as Q3 Sales Rise 34%
Natera raised its 2026 revenue guidance after Q3 revenue rose 34% to $794 million, driven by higher test volumes and strong oncology MRD growth.
Natera Inc
TradingKey
Fri, Nov 6
Stocks
In Step with Global Users, Half a Step Ahead in Innovation: OMODA & JAECOO Drives Next-Generation Mobility Through User Insights
WUHU, China, Nov. 6, 2026 /PRNewswire/ -- AtOMODA X Night on October 20, Mr. Shawn Xu, CEO of OMODA & JAECOO International, shared the brand's global achievements and unveiled its innovation roadmap across new energy, intelligent mobility and next-generation products—marking a new phase of g...
PR Newswire
Fri, Nov 6
Presentations
MannKind Q3 Revenue Rises 24%, Q4 Profit Expected
MannKind’s Q3 2026 revenue rose 24% to $102 million as Furoscix, pediatric Afrezza demand and Tyvaso DPI royalties grew, while the company posted a GAAP net loss.
MannKind Corp
TradingKey
Fri, Nov 6
Presentations
MDU Resources Q3 Profit Falls; Bakken East Moves Forward
MDU Resources’ Q3 2026 profit fell as gas utility and pipeline weakness offset stronger electric earnings. The company reaffirmed guidance and advanced Bakken East.
MDU Resources Group Inc
TradingKey
Fri, Nov 6
Presentations
MasterBrand Posts Q3 Loss, Issues Cautious Q4 Outlook
MasterBrand posted a Q3 loss as weak cabinet demand and inflation pressured margins, while merger synergies advanced and Q4 guidance remained cautious.
Masterbrand Inc
TradingKey
Fri, Nov 6
Forex
Euro: Rotation into Dollar cash caps gains against US Dollar – ING
Chris Turner at ING describes the Euro’s recent performance as unimpressive, with EUR/USD failing to benefit from the US tech sell-off. He argues that European investors are keeping cash in Dollars and that familiar safe-haven correlations with US Treasuries have returned.
EUR/USD
US Dollar Index
Fxstreet
Fri, Nov 6
Presentations
IonQ Q3 Revenue Jumps 336%, 2026 Guidance Raised
IonQ reported Q3 2026 revenue of $173.8 million, raised full-year guidance to $505 million-$515 million and recorded $1.2 billion in remaining performance obligations.
IONQ Inc
TradingKey
Fri, Nov 6
Presentations
ICU Medical Q3 Revenue Rises 4% on Infusion Systems Growth
ICU Medical’s Q3 2026 adjusted revenue rose 4% to $556 million as Infusion Systems and Consumables growth offset a Vital Care decline.
ICU Medical Inc
TradingKey
Fri, Nov 6
Presentations
Honest Raises 2026 Outlook as Q3 Organic Revenue Grows 9.2%
The Honest Company raised its 2026 outlook after Q3 organic revenue grew 9.2%, margins expanded and free cash flow improved, while authorizing a $30 million share repurchase.
Honest Company Inc
TradingKey
Fri, Nov 6
Presentations
Guardant Health Raises 2026 Revenue Outlook as Shield Growth Lifts Q3 Sales
Guardant Health raised its 2026 revenue outlook after Q3 revenue grew 36% to $361 million, led by Shield screening and oncology volume growth.
Guardant Health Inc
TradingKey
Fri, Nov 6
Presentations
GEO Group Q3 Revenue Rises 12% as Adjusted EBITDA Reaches $145 Million
GEO Group’s Q3 2026 revenue rose 11.5% to $761.1 million and adjusted EBITDA increased 21% as secure and managed operations expanded.
Geo Group Inc
TradingKey
Fri, Nov 6
Presentations
Fulgent Genetics Q3 Revenue Rises 8% as Pathology Business Expands
Fulgent Genetics posted 8% Q3 2026 revenue growth as pathology gains offset weaker precision diagnostics, while maintaining $330 million to $340 million annual guidance.
Fulgent Genetics Inc
TradingKey
Fri, Nov 6
Presentations
Five9 Posts 13% Q3 Revenue Growth, Agrees to Buy Level AI for $325 Million
Five9 reported 13% Q3 2026 revenue growth and agreed to acquire Level AI for $325 million, while issuing full-year revenue and earnings guidance.
Five9 Inc
TradingKey
Fri, Nov 6
Presentations
Ducommun Q3 Revenue Rises 6% as Commercial Aerospace Grows 28%
Ducommun reported record Q3 2026 revenue and margins as commercial aerospace sales rose 28%, offsetting a temporary military and space decline.
Ducommun Inc
TradingKey
Fri, Nov 6
Presentations
Castle Biosciences Raises 2026 Revenue Outlook After Q3 Growth
Castle Biosciences raised its 2026 revenue guidance to $385 million-$395 million after Q3 revenue rose about 24%, led by 47% TissueCypher volume growth.
Castle Biosciences Inc
TradingKey
Fri, Nov 6
Commodities
Gold struggles below $4,100 as US Nonfarm Payrolls takes centre stage
Gold (XAU/USD) struggles below $4,100 on Friday after climbing to a two-week high of $4,146 the previous day. A rebound in the US Dollar (USD) weighs on the metal, with attention turning to the US Nonfarm Payrolls report due at 13:30 GMT.
Gold
US Dollar Index
Fxstreet
Fri, Nov 6
Earnings
Humana Q3 2026 Earnings: Revenue Rises as Adjusted EPS Turns Negative
Humana’s Q3 2026 revenue rose about 26% to $41.16 billion, while GAAP diluted EPS fell to $1.33 from $1.62 and adjusted EPS swung to a $0.70 loss from $3.24. The Insurance segment posted a $303 million GAAP operating loss despite a lower operating cost ratio, with a 93.7% benefit ratio. Humana raised full-year adjusted EPS guidance to at least $9.50 and GAAP EPS guidance to at least $15.09, while CenterWell patients and Medicaid membership expanded year to date. The GAAP outlook remains heavily influenced by noncash joint-venture valuation adjustments.
Humana Inc
TradingKey
Fri, Nov 6
1
...
84
85
86
86
/
500
87
88
...
500
Featured Tools
Markets
Economic Calendar
SmartPicks
Weekly Report
Popular Instruments
Name
Price
Chg%
US30
US30
--
--
NAS100
NAS100
--
--
SPX500
US500
--
--
Top News
US October PPI Preview: Fed Rate Hike Expectations Rise, PPI May Be Key Variable; How Will US Stocks, Dollar, and Gold Move?
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
Gold Price Forecast: Gold Tumbles Below $3,900 as Trump Says No Need for Iran Deal; Can October PPI Spur a Rebound?
Cisco Stock Retests $101.60 Ahead of Q1 Results, With AI Orders in Focus
【US Pre-Market】Nvidia Rebounds Over 2%; Microsoft Falls Over 2% Amid Massive Global Outage; October PPI Due
Market Movers
Dell Technologies Inc Stock (DELL) Opened Down by 3.57% on Nov 13: Facts Behind the Movement
27 minutes ago
DELL
--
Advanced Micro Devices Inc Stock (AMD) Opened Down by 5.37% on Nov 13: Facts Behind the Movement
27 minutes ago
AMD
--
Cisco Systems Inc Stock (CSCO) Opened Down by 3.81% on Nov 13: Key Drivers Unveiled
27 minutes ago
CSCO
--
Broadcom Inc Stock (AVGO) Opened Down by 4.37% on Nov 13: A Full Analysis
27 minutes ago
AVGO
--
Arm Holdings PLC Stock (ARM) Opened Down by 3.25% on Nov 13: Drivers Behind the Movement
27 minutes ago
ARM
--